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Purpose: The purpose of this study was to evaluate the importance of experience and the learning curve with endovascular
abdominal aortic aneurysm (AAA) repair.
Methods: A retrospective analysis was performed of all elective endovascular AAA repairs attempted by an individual
surgeon and radiologist over a 4-year period. The primary outcome variable was achievement and 30-day maintenance of
initial clinical success as defined by the Society for Vascular Surgery/American Association of Vascular Surgery reporting
standards. Following standard statistical analysis, the cumulative sum (CUSUM) method was used to analyze the learning
curve, with a predetermined acceptable failure rate of 10% and calculated 80% alert and 95% alarm lines.
Results: Ninety-six elective endovascular AAA repairs were attempted by this team between 1998 and 2002 (mean age 74
 0.8 years; mean aneurysm diameter 5.98  0.8 cm). Initial clinical success was achieved and maintained in 85 of 96
patients (88.5%). Although results were acceptable throughout the study period, improved results with respect to the
target failure rate (10%) were not achieved until 60 patients were treated. The learning or CUSUM curves did not differ
for different device manufacturers, with improved results being achieved following 20 implantations of each device. The
results did differ when comparing aortouniiliac grafts (n  27) and bifurcated grafts (n  64). Results with bifurcated
grafts remained consistent throughout the study period, whereas with aortouniiliac grafts, results improved after only a
few procedures in comparison with the target failure rate.
Conclusion: Success rates with endovascular aneurysm repair will improve with an individual’s experience. The CUSUM
method is a valuable tool in the evaluation of this learning curve, which has credentialing and training implications.
Although acceptable results were obtained throughout the study period, this analysis indicates that 60 endovascular
aneurysm repairs, or 20 with an individual device, are necessary before optimal rates of initial clinical success can be
achieved. These results can be achieved more readily with aortouniiliac grafts than with bifurcated grafts. (J Vasc Surg
2004;39:102-8.)
Since its introduction in the early 1990s,1 vascular
surgeons have found that endovascular aneurysm repair can
be a technically demanding procedure requiring extensive
preoperative planning and, for many practitioners, a new
subset of skills. As with any new intervention or procedure,
there is a learning curve to consider when adopting endo-
vascular aneurysm repair. Although there are several well-
established and widely accepted training and credentialing
guidelines for such endovascular procedures as angiograms
and angioplasties,2,3 there currently exists a distinct lack of
similar recommendations encompassing endovascular an-
eurysm repair. The purpose of this study was to review the
learning curve with respect to elective endovascular abdom-
inal aortic aneurysm repair, using a unique analytical tool.
The contribution of different device manufacturers and
designs was also examined. Such learning curve analyses can
certainly have training and credentialing implications.
Previous single-institution or physician-specific learn-
ing curve analyses employing standard statistical methods
have been disadvantaged, given their retrospective nature
and inability to fully appreciate the role of case volumes in
clinical outcomes. This study uses the cumulative sum
failure method (CUSUM), which is uniquely suited to
learning-curve analysis. Specific advantages include the
consideration of time and experience as a clinical variable
and the ability of the method to be used in a prospective
fashion.
METHODS
The study group consisted of all patients over a 4-year
period (1998-2002) who underwent elective endovascular
abdominal aortic aneurysm repair by a team consisting of an
individual vascular surgeon (G.D.) and interventional radi-
ologist (S.W.K.) at a university-affiliated medical center. A
retrospective review of our endovascular database by an
independent reviewer was performed to obtain demo-
graphic and procedural information. The primary outcome
variable was initial or 30-day clinical success as defined by
the Ad Hoc Committee for Standardized Reporting Prac-
tices in Vascular Surgery of The Society for Vascular Sur-
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gery/American Association for Vascular Surgery.4 Data
regarding clinical success were reported on an intent-to-
treat basis. Briefly, initial clinical success consisted of the
following: successful deployment of the device at the in-
tended location; absence of mortality, type I and III en-
doleak, graft infection, or thrombosis; absence of aneurysm
expansion (diameter 5 mm or volume 5%), aneurysm
rupture, or conversion to open repair; absence of graft
migration or failure of device integrity; absence of type II
endoleak with aneurysm expansion; and maintenance of
above criteria for 30 days.
CUSUM was then used to analyze the learning curve
with endovascular AAA repair. This method recognizes the
importance of time and experience in clinical practice and
allows identification of improved or suboptimal perfor-
mances before their recognition by standard statistical
methods.5 The CUSUM calculation is defined as
Sn  (Xi  Xo), where Xi  0 for initial clinical success
and Xi 1 for initial clinical failure.
5-7 After a review of the
literature, Xo, or the “acceptable initial clinical failure rate,”
was generously set at 10%. Individual CUSUM curves were
then constructed for the entire cohort, for individual en-
dograft manufacturers, and for individual endograft de-
signs. Analysis of these curves involves identification of the
point at which the graph adopts a generally downward
slope. In this study, this point corresponded to the patient
number, following which improved results with respect to
the target success rate began to be observed. In addition,
upper 80% alert and 95% alarm boundary lines and lower
80% reassurance lines were calculated by using a “target
initial clinical failure rate” of 10% and an alternative failure
rate of 20%, which signifies the value at which one wishes to
be alerted if the failure rate rises to this level. CUSUM
curves that cross these 80% and 95% lines correspond to
statistical significance for the entire plotted cohort at the P
 .20 and P .05 levels, respectively. All summary data are
represented by mean  SEM. The formulae used to con-
struct these CUSUM curves are presented in the Appendix
(online only).
RESULTS
Ninety-six patients underwent elective endovascular
repair of an asymptomatic infrarenal abdominal aortic an-
eurysm during this 4-year time period (1998-2002). All
cases were performed by a team consisting of an individual
vascular surgeon (G.D.) and interventional radiologist
(S.W.K.) and were reviewed for the purposes of this study
by an independent observer. Data describing patient demo-
graphics and endograft manufacturers and designs are sum-
marized in Table I. The majority of the study patients were
male (84.4%), with a mean age of 74 0.8 years. The mean
aneurysm diameter was 5.98  0.8 cm. All patients were
assessed as being at high risk for standard open aneurysm
repair because of their comorbid medical conditions. Pre-
operative contrast-enhanced computed tomography scans
and aortograms were performed to confirm aneurysm suit-
ability for endovascular repair. All endovascular repairs
were performed in the operating room with portable C-arm
fluoroscopy.
Three different device manufacturers supplied en-
dografts for these patients. The Talent graft (Medtronic-
World Medical, Sunrise, Fla) was used in the majority of
cases (n  55, 57.3%), followed by the Vanguard (Boston
Scientific, Natick, Mass; n 34, 35.4%) and Zenith (Cook,
Bjaeverskov, Denmark; n 7, 7.3%) devices. Two thirds of
the patients were treated with bifurcated devices (n  64,
66.7%), whereas close to one third of patients were treated
with an aortouniiliac (AUI) design and completed with a
femoral crossover graft (n 27, 28%). The distribution and
frequency of cases in which AUI endografts were used did
not change significantly throughout the study, although
there was a trend toward more AUI grafts in our most
recent experience. At the beginning of the study period,
five patients were treated with a straight tube endograft
(5.2%). These data are summarized in Table I.
Initial or 30-day clinical success was achieved in 85 of
96 patients (88.5%). The causes for failure are listed in
Table II. Frequency of failure did not differ between the
various endograft manufacturers. Four patients died within
30 days of their endovascular repair as a result of cardiac
complications, resulting in an early mortality rate of 4.2%.
This was the most common cause of failure, followed by the
need for conversion to open repair in three patients (3.1%),
a persistent type I endoleak at 30 days in two patients
(2.1%), and endograft limb thrombosis in two patients
(2.1%). Conversion to an open procedure was required in
one patient following avulsion of the external iliac artery
with device delivery, whereas two further patients required
conversion as a result of endograft maldeployment and
resultant renal ischemia. Both patients who suffered from
Table I. Patient demographics and endograft data
Characteristic Data
Mean age (years) 74  0.8
Percentage male 84.4%
Mean aneurysm
diameter (cm)
5.98  0.8
Device manufacturer Talent (Medtronic) (n  55)
Vanguard (Boston Scientific) (n  34)
Zenith (Cook) (n  7)
Device design Bifurcated (n  64)
Aortouniiliac (AUI) (n  27)
Tube/straight (n  5)
Table II. Causes of failure
Number
(N  96) Percentage
Initial clinical success rate 85 88.5
Mortality 4 4.2
Conversion to open repair 3 3.1
Type I endoleak 2 2.1
Limb thrombosis 2 2.1
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early limb thrombosis were treated initially with a bifur-
cated endograft and were revascularized with a femoral
crossover graft and an axillofemoral bypass respectively.
Two patients had a type I endoleak at 30 days that had not
been evident on the completion aortogram. One endoleak
subsequently sealed spontaneously, whereas the other pa-
tient was successfully treated with a proximal aortic exten-
sion. In all cases, an aortogram performed at the comple-
tion of the endovascular procedure and a contrast-
enhanced computed tomography scan and plain abdominal
radiograph at 30 days were used to document any early
endograft-related complications.
CUSUM analysis was subsequently performed, and the
results are summarized in Figs 1-3. These curves include
upper 80% “alert” and 95% “alarm” lines and a lower 80%
“reassurance” line constructed by using the formulae de-
scribed in the Appendix (online only), with a target initial
clinical failure rate (p0) of 10% and an alternative clinical
failure rate (p1) of 20%. The alternative initial clinical failure
rate represents the level at which one wishes to be alerted if
the failure rate rises to this level. The upper boundary lines
represent an unacceptably high failure rate, whereas the
lower boundary line indicates improved results with respect
to the targeted failure rate (10%). Endovascular cases are
then plotted sequentially on the horizontal axis, producing
CUSUM curves that recognize time and experience as
variables. The slope of the resulting curve is important in
analyzing this cumulative data. A flat or horizontal plot
represents satisfactory results compared with the target
failure rate. An upward-sloping curve represents deviation
from acceptable failure rates toward an unacceptably high
rate, whereas a downward-sloping curve depicts improved
results with respect to the target failure rate.
In Fig 1, all 96 patients who underwent attempted
endovascular aneurysm repair are plotted sequentially. The
resulting CUSUM curve remains relatively horizontal and
well within the acceptable range for the first 60 patients.
There is no deviation to the upper “alert” and “alarm”
boundary lines. Following 60 patients, the curve adopts a
generally negative, downward slope, indicating that im-
proved results compared with the 10% target failure rate are
beginning to be achieved. Alternatively, although results
were acceptable throughout the study period, improved
results with respect to the target failure rate were not
achieved until 60 patients were treated. Following the
treatment of approximately 75 patients, the curve crosses
and remains below the lower 80% “reassurance” line, indi-
cating statistical significance for the entire cohort compared
with the target success rate at the P  .20 level.
In Fig 2 the role of different device manufacturers is
shown, with a CUSUM curve plotted for both the Van-
guard and Talent devices. The curves for these manufactur-
ers do not differ. The curves pertaining to the Vanguard
and Talent devices remain within the acceptable range for
the first 20 patients, at which point the curves generally
adopt a negative slope. Alternatively, optimal or improved
results with respect to the target failure rate begin to be
achieved following 20 endovascular repairs with either de-
vice. There is insufficient data to formulate a curve for the
Zenith device, as it was deployed in only seven patients
during this study.
In Fig 3, the role of various device designs is consid-
ered. Aortoaortic tube devices were only used in five cases,
so an adequate CUSUM analysis is impractical. However,
when the curves describing our experience with AUI and
bifurcated endografts are compared, there is a clear differ-
ence. Although results with bifurcated grafts remain con-
sistent and acceptable throughout the study period, results
with the AUI endografts improved after only several pro-
Fig 1. CUSUM: Initial clinical success. Fig 2. CUSUM: Device manufacturer.
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cedures in comparison with the target failure rate. Fewer
repairs with the AUI design were required to achieve
optimal results compared with bifurcated grafts.
DISCUSSION
Although it seems reasonable that results with respect
to any technical procedure will improve with experience,
few studies have attempted to analyze the learning curve
associated with endovascular aneurysm repair. Those that
have been published have used a variety of statistical meth-
ods to examine this learning curve.8-11 These studies often
fail to make recommendations that are applicable to an
individual surgeon’s learning curve and experience.
Lee and colleagues8 from Stanford described their ex-
perience with a single device (AneuRx, Medtronic AVE,
Santa Rosa, Calif) by dividing their first 150 consecutive
patients into two temporal groups of 75 cases each. This
group used the achievement of technical success as the
major outcome variable.12 A standard statistical analysis
revealed no significant difference between the two groups
with respect to technical success. However, there was a
statistically significant decreased need for femoral artery
reconstruction and fluoroscopy time in the second group.
In addition, this analysis noted a trend toward less need for
proximal extender cuffs in the second group of 75 patients.
On the basis of their study, the Stanford group concluded
that a learning curve did exist and that with more experi-
ence, decreased fluoroscopy times, more accurate deploy-
ment, and fewer access complications could be accom-
plished. By using a single device, this analysis does not allow
one to comment on the role of different device manufac-
turers in the learning curve. As well, this form of analysis is
not able to offer recommendations with respect to the
volume of cases necessary to achieve optimal results with
endovascular aneurysm repair. As an institutional experi-
ence, these results may not be applicable to an individual
surgeon’s learning curve.
Lobato and the Arizona Heart Institute group9 ana-
lyzed the learning curve by using a first-order differential
equation to examine their 277 cases. As with the Stanford
group, technical success was the main outcome variable.12
This study concluded that 55 endovascular aneurysm re-
pairs were needed to achieve optimal results and that the
time interval between procedures was also important, with
one case every 10 days being the minimal frequency to
achieve these success rates. This group used several differ-
ent device manufacturers and designs and found that these
did not influence the learning curve. As with the previous
study, this institutional experience may not be transferable
to an individual practitioner’s learning experience.
The EUROSTAR collaborators10 analyzed the contri-
bution of case volumes to results in their extensive data-
base. Main outcomes were patient mortality, aneurysm
rupture, and the need for secondary endovascular interven-
tions. Specialist teams, using several device manufacturers,
were ranked into quartiles on the basis of case volumes,
with the lowest-experience quartile being the first 11 cases
and the highest quartile being patient 92 or more. The
study concluded that more experienced endovascular teams
had lower mortality rates and fewer complications leading
to secondary interventions. Aneurysm rupture did not
change with experience. The authors suggested that 38 of
their patients needed to be treated before a decrease in
perioperative mortality and 92 patients may have needed
treatment before a reduction in secondary interventions
could be achieved. On the basis of these data, the authors
recommended that the mentoring or proctoring process
with endovascular aneurysm repair needs to be longer than
is currently the case.
As opposed to these retrospective analyses of institu-
tional experiences, an individual surgeon’s learning curve
would optimally be assessed as results are being achieved.
Although applied retrospectively in the present study, the
CUSUM failure technique is appropriate for prospective
learning curve analyses. This would allow for the recogni-
tion of suboptimal outcomes earlier than their identifica-
tion with standard post hoc statistical analytical tools. The
CUSUM method was first described in 1950,13 and its
value as an analytical tool for medical data was almost
immediately realized.14 Essentially, CUSUM analysis re-
peatedly applies a sequential probability test to any data
whose results can be simplified to either a “success” or
“failure.” In this study, success is the achievement of initial
clinical success, and failure is the lack of this achievement. A
target or reference rate of performance is determined, and
the slope of the resulting graph is analyzed. Suboptimal
results compared with the target failure rate are represented
by a positive slope, whereas a negative slope demonstrates
improved results compared with the target rate.5,15,16
Despite its relative simplicity, the CUSUM method has
been underused in the analysis of surgical data. This has
Fig 3. CUSUM: Device design.
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changed somewhat recently with the publication of several
reports in which various groups have described their use of
CUSUM analysis in the setting of colonoscopy,17 abdom-
inal ultrasound in trauma patients,18 the treatment of myo-
cardial infarction,19 surgical training,20 and cardiac sur-
gery.21 At our institution, Novick and colleagues have
increased the awareness of this tool by reviewing the learn-
ing curve in a cardiac surgeon’s early years of practice6 as
well as change to off-pump coronary artery bypass graft-
ing.7,22 This experience prompted our group to use this
analytical tool to review the learning curve of an individual
surgeon with respect to repair of ruptured abdominal aortic
aneurysms.23
In this study we set out to analyze our learning curve
with endovascular aneurysm repair with this unique analyt-
ical tool. The target failure rate was obtained following a
review of the literature, in which technical and clinical
success rates with endovascular aneurysm repair ranged
from 73.3% to 95%.24-32 For the purpose of this learning
curve analysis, the target initial clinical success rate was set
at 90%, or a target (or acceptable) failure rate of 10%. This
measure of success was chosen for this analysis as it takes
into account short-term follow-up along with initial proce-
dural technical success. Initial clinical success, as defined by
the Society for Vascular Surgery/American Association for
Vascular Surgery, is a better marker of a surgeon’s experi-
ence and learning curve than is technical success, as it
considers the often-intensive patient and device selection
phase of endovascular procedures along with the actual
technical performance of the procedure. Certainly several
of the factors necessary for initial clinical success (the need
for conversion to open repair, and type I endoleak) have
been observed less frequently with increased experi-
ence.27,33 The period of preoperative planning often plays
more of a role in achieving optimal results than does the
actual performance of the endovascular repair. Following
the initial perioperative period, reasons other than surgeon
experience that are more specific to patient and graft dy-
namics may result in failure of the endovascular approach.
Up to this point, few studies have investigated the role
of surgical volumes with outcomes in vascular sur-
gery.23,34,35 The CUSUM failure method is uniquely
suited to analyze this relationship with respect to an indi-
vidual’s experience. This study reviewed the learning curve
of an endovascular team comprising a vascular surgeon and
interventional radiologist. The 88.5% initial clinical success
rate achieved by this team over a 4-year period compares
favorably with published data.24-33,36-42 A sequential
CUSUM plot of all endovascular repairs performed by this
team (Fig 1) indicates that 60 endovascular aneurysm re-
pairs are required to achieve a target initial clinical success
rate of 90%. This case volume is irrespective of device design
or manufacturer. Although similar to the results obtained
by the institutional learning curve analysis performed at the
Arizona Heart Institute,9 this study’s results are more
applicable to what an individual may expect with respect to
his or her learning experience.
Previous studies have failed to reveal a role for different
device manufacturers in the evolution of results over time
with endovascular aneurysm repair.9,10 However, as spe-
cific device manufacturers differ with respect to preopera-
tive case planning, device design, measurements, and de-
ployment, it is not unreasonable to expect a manufacturer-
specific learning curve.26,32,39,42 As several procedural
steps are common to all endovascular repairs, we recognize
that the learning curve with one device influences results
with other devices, with there being significant interaction
in the acquisition of experience. Despite this interaction,
this study attempted to compare the learning curves with
respect to several different endograft manufacturers. A
sequential CUSUM graph of aneurysm repairs performed
with different device manufacturers (Fig 2) indicated that
20 repairs are required for a team, or individual, to obtain
optimal results, defined in this study as an initial clinical
success rate of 90%. This did not differ between the two
devices that were predominantly used at our institution
during this time period. Although we have not had exten-
sive experience with other manufacturers, we see no reason
why this manufacturer-specific learning curve should not be
applicable to the use of other companies’ designs.
During the relatively brief history of endovascular an-
eurysm repair, it has become apparent that endograft device
design is a vital contributor to successful aneurysm exclu-
sion.37 As in other institutions, several aortoaortic tube
endografts were deployed at our center early in our endo-
vascular experience. We have since abandoned the use of
this design given the widespread concern regarding distal
aortic attachment site complications and device migra-
tion.24 Since then, two thirds (66.7%) of the endovascular
aneurysm repairs performed by this team have used bifur-
cated grafts, whereas AUI devices were deployed in approx-
imately one third of cases (28%). A CUSUM plot of our
experience with these different designs (Fig 3) confirms
that satisfactory results, with respect to target initial clinical
success rates, can be obtained with either design. However,
vastly improved results compared with target rates are
obtained following fewer repairs with AUI devices than
with bifurcated endografts. This is in no small part the
result of an increased risk of limb thrombosis with bifur-
cated grafts. Although this trend has not been universally
observed, it is felt that the use of a bifurcated graft is one
factor that may contribute to limb thrombosis, along with
other factors such as the use of an unsupported limb, small
limb diameter, and extension to the external iliac ar-
tery.25,40,41 In comparison, very few instances of endograft
limb or femoral crossover graft thrombosis have been re-
ported following the use of an AUI device. In this instance,
published primary and secondary patency rates approach
98% and 100%, respectively.43 For these reasons, we have
developed a distinct preference for the AUI design in our
most recent endovascular experience and feel that it has
wider applicability than the bifurcated design in patients
with extensive aortoiliac aneurysmal disease.
A limitation of this analysis is that, although it is useful
in assessing an individual’s learning curve, it does not allow
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comment on the time interval between cases. It would be
logical to expect improved outcomes with shorter time
intervals between interventions. Other forms of analyses,
such as a first-order differential equation, have been used to
evaluate this relationship.9 In addition, the length of the
learning curve is inversely proportional to the predeter-
mined target or acceptable failure rate. Shorter learning
curves can be achieved by setting the acceptable failure rate
at a higher level. Although this rate is somewhat arbitrarily
set, it should be derived from previously published data, as
in this study.
Learning-curve analyses such as these have training and
credentialing implications. Although training guidelines
have been published,2,3,44 few have determined sufficient
case volumes of endovascular aneurysm repair to obtain
optimal results. This study reinforces the importance of the
proctoring system during the preoperative planning phase
as well as the technical application of this technology. Our
group received industry-provided technical training fol-
lowed by supervision by an experienced endovascular sur-
geon during the preoperative planning phase and intraop-
erative phase for the first half-dozen cases. Following this
period, the various manufacturers provided on-site techni-
cal support and advice during the procedures, for varying
durations. Some investigators have advocated the use of
simulators in endovascular training.45 Although this may
improve one’s technical endovascular skills, simulators
alone are not sufficient to obtain optimal clinical results.
These results can only be achieved with further experience
in the preoperative planning and measurement phase of
endovascular aneurysm repair, along with superior techni-
cal skills.
CONCLUSIONS
This study illustrates the value of the CUSUM tech-
nique in evaluating an individual’s learning curve. Al-
though acceptable results were achieved throughout the
study period with respect to endovascular aneurysm repair,
this study’s results indicate that 60 elective endovascular
repairs, or 20 with an individual device manufacturer, are
required to obtain optimal results with respect to initial
clinical success. In addition, these improved results can be
achieved with fewer repairs with AUI devices than with
bifurcated endografts.
We thank Dr Richard Novick for his assistance and
advice with respect to the CUSUM calculations and statis-
tical analysis.
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